Cooperative Relationship Between Pharmaceutical Companies, Academia, and Media Explains Sharp Decrease in Frequency of Pulmonary Complications After Bortezomib in Japan
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.